In colorectal cancer, it was reported that the KRAS4B isoform is selectively overexpressed and thus, the ratio of KRAS4A/4B isoforms is reduced during colorectal carcinogenesis, suggesting that KRAS4B might be more tumorigenic than KRAS4A [24, 25]. This evidence concerns the gene KRAS and colorectal cancer.